Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
Insulin as part (rDNA origin) injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days ...
Novolin N vial (Novo Nordisk) 30 days Prescribing information Regular human insulin injection (rDNA origin) Novolin R vial (Novo Nordisk) 30 days Prescribing information Humulin Ultralente human ...
The companion app for the InPen digital insulin pen is designed to connect with the company’s latest Simplera continuous glucose monitor, offering users personalized dosing suggestions based on ...
The medical device manufacturer Owen Mumford has announced that it will stop producing its Autopen range of insulin delivery pens. Here, we look at what this means for people with diabetes who might ...
They are calling for the Danish multinational to withdraw its decision to discontinue its provision of human insulin pens “in South Africa and other developing countries”. MSF also wants the ...
The regulatory clearance paves the way for the launch of the company’s “Smart MDI” system, including a smart insulin pen that tracks doses and a body worn monitor that makes real-time ...
Here’s how it works. The Surface Pen and Surface Slim Pen 2 are the best options for modern Surface PCs; I've been using the former for years without issue, and the latter adds wireless charging ...
(Bloomberg) -- About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater access to its human insulin and lower prices, while also ...
Novo Nordisk lowered the list price on various insulin products, including pre-filled insulin pens and vials. The company suggested that this would mean patients would pay $25-35 for their insulin.